Atlas Trials

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

Clinical trial NCT01633112 · TERMINATED

Trial details

NCT number
NCT01633112
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis (RRMS)
Start date
2012-08-09
Primary completion
2018-04-30
Enrollment
1064

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.